MSS
ABBV icon

Mitchell Sinkler & Starr’s AbbVie ABBV Stock Holding History

Mitchell Sinkler & Starr’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.38M Sell
13,417
-250
-2% -$53.8K 1.41% 16
2026
Q1 		$2.97M Sell
13,667
-60
-0.4% -$13.3K 1.37% 19
2025
Q4 		$3.14M Buy
13,727
+230
+2% +$52.4K 1.42% 17
2025
Q3 		$3.13M Hold
13,497
– – 1.41% 19
2025
Q2 		$2.51M Sell
13,497
-55
-0.4% -$10.2K 1.2% 23
2025
Q1 		$2.84M Sell
13,552
-1,432
-10% -$278K 0.79% 33
2024
Q4 		$2.66M Sell
14,984
-13,165
-47% -$2.42M 0.71% 34
2024
Q3 		$3.99M Buy
28,149
+5,812
+26% +$1.08M 1% 30
2024
Q2 		$3.83M Buy
22,337
+720
+3% +$119K 0.98% 30
2024
Q1 		$3.94M Sell
21,617
-40,205
-65% -$6.93M 0.98% 29
2023
Q4 		$9.58M Buy
61,822
+29,822
+93% +$4.35M 1.74% 18
2023
Q3 		$4.77M Buy
32,000
+7,238
+29% +$1.06M 1.47% 20
2023
Q2 		$3.34M Sell
24,762
-575
-2% -$84.3K 0.95% 28
2023
Q1 		$4.04M Buy
25,337
+6,867
+37% +$1.05M 1.19% 26
2022
Q4 		$2.98M Buy
18,470
+590
+3% +$90.5K 0.96% 27
2022
Q3 		$2.4M Sell
17,880
-665
-4% -$95.4K 0.93% 26
2022
Q2 		$2.84M Buy
18,545
+125
+0.7% +$19.1K 1.04% 26
2022
Q1 		$2.99M Buy
18,420
+1,310
+8% +$190K 0.93% 26
2021
Q4 		$2.32M Buy
17,110
+295
+2% +$34.8K 0.69% 33
2021
Q3 		$1.81M Sell
16,815
-75
-0.4% -$8.57K 1.64% 17
2021
Q2 		$1.9M Hold
16,890
– – 1.73% 15
2021
Q1 		$1.83M Sell
16,890
-180
-1% -$19.3K 1.77% 13
2020
Q4 		$1.83M Hold
17,070
– – 1.75% 17
2020
Q3 		$1.5M Buy
17,070
+365
+2% +$34.4K 1.52% 21
2020
Q2 		$1.64M Sell
16,705
-2,100
-11% -$185K 1.86% 16
2020
Q1 		$1.43M Sell
18,805
-525
-3% -$44.7K 1.87% 15
2019
Q4 		$1.71M Sell
19,330
-605
-3% -$50.2K 1.82% 18
2019
Q3 		$1.51M Sell
19,935
-4,371
-18% -$300K 1.93% 17
2019
Q2 		$1.77M Sell
24,306
-100
-0.4% -$7.86K 2.02% 15
2019
Q1 		$1.97M Sell
24,406
-1,125
-4% -$92K 2.27% 12
2018
Q4 		$2.35M Sell
25,531
-1,820
-7% -$160K 2.91% 3
2018
Q3 		$2.59M Sell
27,351
-1,035
-4% -$98.2K 2.71% 5
2018
Q2 		$2.63M Sell
28,386
-1,650
-5% -$161K 2.9% 2
2018
Q1 		$2.84M Buy
30,036
+8,398
+39% +$923K 3.24% 1
2017
Q4 		$2.09M Sell
21,638
-666
-3% -$62.8K 3.1% 3
2017
Q3 		$1.98M Hold
22,304
– – 3.11% 3
2017
Q2 		$1.62M Sell
22,304
-800
-3% -$53.8K 2.65% 5
2017
Q1 		$1.5M Sell
23,104
-340
-1% -$21.4K 2.44% 7
2016
Q4 		$1.47M Sell
23,444
-2,780
-11% -$170K 2.06% 15
2016
Q3 		$1.65M Hold
26,224
– – 2.59% 9
2016
Q2 		$1.62M Hold
26,224
– – 2.21% 13
2016
Q1 		$1.5M Sell
26,224
-800
-3% -$44.6K 2.07% 14
2015
Q4 		$1.6M Sell
27,024
-3,000
-10% -$173K 2.19% 14
2015
Q3 		$1.63M Hold
30,024
– – 2.1% 12
2015
Q2 		$2.02M Sell
30,024
-110
-0.4% -$7.18K 2.38% 10
2015
Q1 		$1.76M Sell
30,134
-25
-0.1% -$1.51K 1.98% 18
2014
Q4 		$1.97M Sell
30,159
-400
-1% -$25.2K 2.21% 14
2014
Q3 		$1.76M Sell
30,559
-807
-3% -$44.8K 1.97% 18
2014
Q2 		$1.77M Buy
31,366
+800
+3% +$42K 1.9% 18
2014
Q1 		$1.57M Sell
30,566
-215
-0.7% -$10.9K 1.76% 23
2013
Q4 		$1.63M Sell
30,781
-2,600
-8% -$128K 1.83% 19
2013
Q3 		$1.49M Sell
33,381
-200,200
-86% -$8.87M 1.71% 23
2013
Q2 		$9.66M Buy
+233,581
New +$10.2M 2.12% 10

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Mitchell Sinkler & Starr's ABBV Position: Q2 2026 in Review

Mitchell Sinkler & Starr reduced its AbbVie (ABBV) stake by 1.8% in Q2 2026, selling an estimated $53.8K and leaving 13,417 shares worth $3.38M. The position accounts for 1.41% of the portfolio, ranked #16.

Mitchell Sinkler & Starr first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.66M in Q2 2013. 1,414 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Mitchell Sinkler & Starr held 13,417 shares of AbbVie worth $3.38M as of Q2 2026.
  • Mitchell Sinkler & Starr sold 250 AbbVie shares in Q2 2026, an estimated $53.8K.
  • AbbVie made up 1.41% of Mitchell Sinkler & Starr's portfolio in Q2 2026, its #16 holding.
  • Mitchell Sinkler & Starr first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Mitchell Sinkler & Starr's AbbVie position peaked at $9.66M in Q2 2013.
  • 1,414 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2026, filed 21 Jul 2026.